Corcept Therapeutics
CORT
#3014
Rank
ยฃ3.25 B
Marketcap
ยฃ31.18
Share price
-3.19%
Change (1 day)
17.43%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): ยฃ0.45 B

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM) is ยฃ0.43 B. In 2023 the company made a revenue of ยฃ0.37 B an increase over the revenue in the year 2022 that were of ยฃ0.33 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.45 B19.73%
2023 ยฃ0.37 B13.99%
2022 ยฃ0.33 B22.83%
2021 ยฃ0.27 B4.32%
2020 ยฃ0.25 B12.24%
2019 ยฃ0.23 B17.29%
2018 ยฃ0.19 B67.16%
2017 ยฃ0.11 B78.73%
2016 ยฃ65.9 M94.43%
2015 ยฃ33.89 M98.74%
2014 ยฃ17.05 M171.98%
2013 ยฃ6.27 M206.65%
2012 ยฃ2.04 M
2011 N/A
2010 N/A-100%
2009 ยฃ0.01 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ65.96 B 15,099.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ35.43 B 8,065.06%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ37.22 B 8,477.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ29.65 B 6,733.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.39 B 9,668.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.60 B 10,868.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.21 B-51.23%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.18 B-56.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.97 B 354.42%๐Ÿ‡บ๐Ÿ‡ธ USA